Reversible renal failure in a patient with the hypereosinophilia syndrome during therapy with alpha interferon

American Journal of Kidney Diseases

Volumn 31, Issue 1, 1998, Pages 121-126

  Nassar, George M ^a,b   Pedro, Paul ^a   Remmers, Rebecca E ^a   Mohanty, Laxmi B ^a   Smith, Wade ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Hypereosinophilia; Interferon alpha; Nephrotoxicity

Indexed keywords

COMPLEMENT COMPONENT C3; CREATININE; HYDROXYUREA; NITROGEN; PREDNISONE; RECOMBINANT ALPHA2B INTERFERON; UREA;

ADULT; ARTICLE; BLOOD CELL COUNT; CASE REPORT; ELECTRON MICROSCOPY; HEMODIALYSIS; HUMAN; HYPEREOSINOPHILIA; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; MICROSCOPY; NEPHROTOXICITY; PROTEINURIA; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031950816     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v31.pm9428462     Document Type: Article

References (27)

1. Quesada J, Talpaz M, Rios A, Kurzrock R, Gutterman J: Clinical toxicity of interferons in cancer patients: A review. J Clin Oncol 4:234-243, 1986
2. Jones GJ, Itri LM: Safety and tolerance of recombinant interferon alfa-2α (Roferon-A) in cancer patients. Cancer 57:1709-1715, 1986
3. Averbach S, Austin H, Sherwin S, Antonovych T, Bunn P, Longo D: Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte A interferon therapy for mycosis fungoides. N Engl J Med 310:32-35, 1984
4. Selby P, Kohn J, Raymond J, Judson I, McElwain T: Nephrotic syndrome during treatment with interferon. BMJ 290:1180, 1985
5. Herrman J, Gabriel F: Membranoproliferative glomerulonephritis in a patient with hairy-cell leukemia treated with alpha-II interferon. N Engl J Med 316:112-113, 1987
6. Ault BH, Stapleton FB, Gaber L, Martin A, Roy S, Murphy SB: Acute renal failure during therapy with recombinant human gamma interferon. N Engl J Med 319:1397-1400, 1988
7. Nair S, Ernstoff MS, Bahnson RR, Arthur S, Johnston J, Downs MA, Neuhart J, Kirkwood JM: Interferon-induced reversible acute renal failure with nephrotic syndrome. Urology 34:169-172, 1992
8. Lederer E, Truong L: Unusual glomerular lesion in a patient receiving long-term interferon alpha. Am J Kidney Dis 20:516-518, 1992
9. Noel C, Vrtovsnik F, Facon T, Noel-Walter MP, Hazzan M, Jouet JP, Bauters F, Lelievre G: Acute and definitive renal failure in progressive multiple myeloma treated with recombinant interferon alpha-2α: Report on two patients. Am J Hematol 41:298-299, 1992
10. Sawamura M, Matsushima T, Tamura J, Murakami H, Tsuchiya J: Renal toxicity in long-term alpha interferon treatment in a patient with myeloma. Am J Hematol 41:146, 1992
11. Ayub A, Zafar M, Al-Harbi A, Ellis M, Qunibi W: Acute renal failure with α-interferon therapy: A case report. Med Sci Res 21:123-124, 1993
12. Stratta P, Canavese C, Dogliani M, Thea A, Degani G, Mairone L, Vercellone A: Hemolytic-uremic syndrome during recombinant α-interferon treatment for hairy cell leukemia. Ren Fail 15:559-561, 1993
13. Hansen PB, Johnsen HE, Hippe E: Hypereosinophilic syndrome treated with α-interferon and granulocyte colony-stimulating factor but complicated by nephrotoxicity. Am J Hematol 43:66-68, 1993
14. Traynor A, Kuzel T, Samuelson E, Kanwar Y: Minimal-change glomerulopathy and glomerular visceral epithelial hyperplasia associated with alpha-interferon therapy for cutaneous T-cell lymphoma. Nephron 67:94-100, 1994
15. Parker MG, Atkins MB, Ucci AA, Levey AS: Rapidly progressive glomerulonephritis after immunotherapy for cancer. J Am Soc Nephrol 5:1740-1744, 1995
16. Jadoul M, Piessevaux H, Ferrant A, Cosyns JP, van Ypersele de Stihou C: Renal thrombotic microangiopathy in patients with chronic myelogenous leukemia treated with interferon-α2b. Nephrol Dial Transplant 10:111-113, 1995
17. Kurschel E, Metz-Kurschel U, Niederie N, Aulbert E: Investigations on the subclinical and clinical nephrotoxicity of Interferon α-2B in patients with myeloproliferative syndromes. Ren Fail 13:87-93, 1991
18. Gresser I, Maury C, Tovery M, Morel-Maroger L, Pontillon F: Progressive glomerulonephritis in mice treated with interferon preparations at birth. Nature 263:420-422, 1976
19. Morel-Maroger L, Sloper JC, Vinter J, Woodrow D, Gresser I: An ultrastructural study of the development of nephritis in mice treated with interferon in the neonatal period. Lab Invest 39:513-522, 1978
20. Gresser I, Aguet M, Morel-Maroger L, Woodrow D, Puvion-Dutilleul F, Guillon JC, Maury C: Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice. Am J Pathol 102:396-402, 1981
21. Adam C, Thoua Y, Ronco P, Verroust P, Tovery M, Morel-Marogen L: The effect of exogenous interferon: Acceleration of autoimmune and renal disease in (NZB/W) F1 mice. Clin Exp Immunol 40:373-382, 1980
22. Woodrow D, Ronco P, Riviere Y, Moss J, Gresser I, Guillon JC, Morel-Maroger L, Sloper JC, Verroust P: Severity of glomerulonephritis induced in different strains of suckling mice by infection with lymphocytic chorimeningitis virus: Correlation with amounts of endogenous interferon and circulating immune complexes. J Pathol 138:325-336, 1982
23. Ronco P, Woodrow D, Riviere Y, Moss J, Verroust P, Guillon JC, Gresser I, Sloper JC, Morel-Maroger L: Further studies on the inhibition of lymphocytic choriomeningitis-induced glomerulonephritis by antiinterferon globulin. Lab Invest 43:37-46, 1980
24. Ronnblom LE, Alm GV, Oberg KE: Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 115:178-183, 1991
25. Kramer P, Ten Kate FWJ, Bijnen AB: Recombinant leukocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients. Lancet 1:989-990, 1984
26. BinoT, Madar Z, Gertler A, Rosenberg H: The kidney is the main site of interferon degradation. J Interferon Res 2:301-308, 1982
27. Vial T, Descotes J: Clinical toxicity of the interferons. Drug Safety 10:115-150, 1994